II
NBIX icon

Inspire Investing’s Neurocrine Biosciences NBIX Stock Holding History

Inspire Investing’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$939K Buy
7,126
+4,786
+205% +$635K 0.05% 343
2025
Q4 		$332K Buy
2,340
+148
+7% +$21.4K 0.03% 743
2025
Q3 		$308K Sell
2,192
-46
-2% -$6.23K 0.03% 795
2025
Q2 		$281K Sell
2,238
-512
-19% -$58.7K 0.03% 766
2025
Q1 		$304K Buy
2,750
+861
+46% +$109K 0.04% 785
2024
Q4 		$258K Sell
1,889
-580
-23% -$71.7K 0.03% 809
2024
Q3 		$284K Sell
2,469
-2,054
-45% -$282K 0.03% 806
2024
Q2 		$623K Sell
4,523
-7,773
-63% -$1.07M 0.07% 283
2024
Q1 		$1.7M Buy
12,296
+6,045
+97% +$826K 0.17% 145
2023
Q4 		$824K Sell
6,251
-5,247
-46% -$604K 0.09% 236
2023
Q3 		$1.29M Sell
11,498
-10,526
-48% -$1.11M 0.17% 164
2023
Q2 		$2.08M Buy
22,024
+1,287
+6% +$126K 0.25% 95
2023
Q1 		$2.1M Buy
20,737
+5,282
+34% +$550K 0.27% 93
2022
Q4 		$1.85M Buy
15,455
+13,506
+693% +$1.58M 0.24% 91
2022
Q3 		$207K Buy
+1,949
New +$198K 0.03% 517
2020
Q2 		– Sell
-76
Closed -$7K – 632
2020
Q1 		$7K Buy
+76
New +$7.44K ﹤0.01% 720
2018
Q1 		– Sell
-7
Closed -$1K – 513
2017
Q4 		$1K Buy
+7
New +$477 ﹤0.01% 880

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's NBIX Position: Q1 2026 in Review

Inspire Investing increased its Neurocrine Biosciences (NBIX) stake by 205% in Q1 2026, buying an estimated $635K and bringing the position to 7,126 shares worth $939K. The position accounts for 0.05% of the portfolio, ranked #343.

Inspire Investing first reported a position in NBIX in Q4 2017 and has held it in 17 quarters since. The position peaked at $2.1M in Q1 2023. 695 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Inspire Investing held 7,126 shares of Neurocrine Biosciences worth $939K as of Q1 2026.
  • Inspire Investing bought 4,786 Neurocrine Biosciences shares in Q1 2026, an estimated $635K.
  • Neurocrine Biosciences made up 0.05% of Inspire Investing's portfolio in Q1 2026, its #343 holding.
  • Inspire Investing first reported a position in Neurocrine Biosciences in Q4 2017 and has held it in 17 quarters since.
  • Inspire Investing's Neurocrine Biosciences position peaked at $2.1M in Q1 2023.
  • 695 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.